Biblio Discovery — Demo Discovery Service

318 hasil

Menampilkan 1–20 · 0,36 detik · RSS

Jurnal

Journal of Market Access & Health Policy

Scopus

ISSN 2001-6689 · MDPI AG · 318 artikel di indeks

  1. Artikel Jurnal Teks lengkap

    Role of General Practitioners in European Health Technology Assessment, EU-HTA Innovation in Oncology as an Example

    Daniel Widmer; Hermenegildo Marcos Carrera; Jörg Ruof dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Introduction: Different from established clinical guideline workstreams, the participation of general practitioners (GPs) in the health technology assessment (HTA) process at the European level is new. There is a research gap in this domain. The European Union of General Practitioners (UEMO) is the…

  2. Artikel Jurnal Teks lengkap

    Parent-Reported Satisfaction, Perceived Child Acceptance, and Ease of Administration of a Strawberry-Flavoured Ibuprofen Suspension for Children: A Cross-Sectional Survey of Experienced Users in Germany

    Kerstin Weber; Spasenija Bradic; Gábor Kertes dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: Palatability and ease of administration are recognised as key determinants of medication adherence in paediatric populations. Oral ibuprofen suspensions are among the most commonly used analgesic and antipyretic medications for children in Germany, yet parental and parent-perceived…

  3. Artikel Jurnal Teks lengkap

    Analysis of Factors Influencing Drug Prices Differently in Official Drug Pricing and Cost-Effectiveness Evaluation

    Mariko Hara; Hiroshi Nakamura

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: In Japan, official prices of pharmaceuticals have been determined by efficacy and safety. In 2019, Cost-Effectiveness Evaluation (CEE) was introduced to adjust these prices according to Incremental Cost-Effectiveness Ratios (ICERs). Objectives: To analyze the differences in the factors…

  4. Artikel Jurnal Teks lengkap

    The Post-Authorisation Maze: Mapping of European Pharmaceutical Market Access Pathways in the Early JCA Era

    Lisa-Maria Hagemann; Karolin Eberle; Jana Maurer dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The Regulation (EU) 2021/2282 on health technology assessment (HTAR) harmonises clinical evidence assessment across Europe. However, national appraisal, pricing, and reimbursement processes remain divergent and could affect the efficiency of decision-making and patient access. Here we mapped the…

  5. Artikel Jurnal Teks lengkap

    Real-World Shelf Life of Epinephrine Auto-Injectors in Canada: Implications for Renewal Frequency and Patient Burden

    John Papastergiou; Mille Vang Lybech; Christoffer Mertz dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Although patients in Canada at risk of anaphylaxis are recommended to maintain access to two in-date epinephrine auto-injectors (EAIs) at all times, underuse during emergencies remains common. Multiple factors contribute to this gap, but the impact of real-world shelf life has been understudied…

  6. Artikel Jurnal Teks lengkap

    Procedural Theatre: EU-HTA Between Ritual and Purpose—Why the Buyer’s Audit Has Outgrown the Transaction

    Mondher Toumi; Maarten Jacobus Postma; Bruno Falissard dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Health technology assessment is a discipline that has developed, over five decades, an elaborate scientific and institutional identity centered on the evaluation of clinical evidence, comparative effectiveness, and economic value [...]

  7. Artikel Jurnal Teks lengkap

    A Model-Based Public-Payer Investment Appraisal of a National Home Hemodialysis Program in Greece: A Net Present Value Analysis

    Vasileios Zavvos; John Fanourgiakis; Michael A. Talias dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: In-center hemodialysis is the dominant kidney replacement therapy modality in Greece and generates substantial recurring expenditure for the public payer. Home hemodialysis is not currently implemented at national scale, but it may reduce long-term public expenditure if early investment…

  8. Artikel Jurnal Teks lengkap

    Valuation of Medical Innovation in Orphan Diseases with a Focus on Small Investors and Limited Diversifiable Risks

    Mark Nuijten; Pieter van Gelder

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    This paper assesses the impact of uncertainty for investors on the economic valuation of medical innovation projects for orphan drugs or rare diseases. Conventionally, investor evaluation uses the deterministic discounted cash flow (DCF) method with an appropriate sensitivity analysis that captures…

  9. Artikel Jurnal Teks lengkap

    Health-Related Quality of Life of Patients with Epidermolysis bullosa and Carers Using a Time Trade-Off Approach in the UK General Population to Elicit Utilities for Health Technology Assessment

    Luke Stainer; George Morgan; Thomas Snell dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: Epidermolysis bullosa (EB) is a complex group of rare, inherited skin disorders that blister easily, imposing substantial burden on patients and carers. There is a lack of published evidence in the UK quantifying health-related quality of life in EB patients and carers as utility values…

  10. Artikel Jurnal Teks lengkap

    From Joint Clinical Assessment to National Decisions: EU HTA Implementation and Implications for Patient Access

    Kalpana D’Oca; Ada Adriano; Eline Darquennes dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The introduction of Joint Clinical Assessments (JCAs) under the European Union Health Technology Assessment Regulation (EU HTAR) represents a major structural reform aimed at reducing fragmentation and duplication in clinical evidence assessment across Member States. While JCAs are intended to…

  11. Artikel Jurnal Teks lengkap

    Treatment Preferences in Acute Allergic Reactions—How Can the Context Impact the Preference for a Corticosteroid Mouth Film Versus Conventional Tablets?

    Andrea Karadak; Karin Wahlberg; Göran Tornling dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: The objective was to assess how preferences for a self-dissolving dexamethasone mouth film versus conventional tablets for acute allergic reactions may vary according to population characteristics and the level of outcome knowledge for the intervention (i.e., ex ante, interim, and ex…

  12. Artikel Jurnal Teks lengkap

    The European Union’s Health Technology Assessment Regulation (EU-HTA R) Will Prosper Despite Major Setbacks

    Mondher Toumi; Imen Soussi; Bruno Falissard dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: The EU Health Technology Assessment Regulation (EU-HTA R), effective January 2025, mandates Joint Clinical Assessments (JCAs) to harmonize HTA across Member States. However, its implementation raises fundamental questions about methodological coherence, institutional capacity, and…

  13. Artikel Jurnal Teks lengkap

    Guidance on Multiplicity Analysis in Single-Trial Assessments: A No-Solution Equation

    Mondher Toumi; Bruno Falissard; Asma Jouini dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The European Health Technology Assessment (EU HTA) guidance on Multiplicity of Hypothesis Testing (MHT) [...]

  14. Artikel Jurnal Teks lengkap

    Direct Public-Payer Costs of Dialysis Therapies in Greece: A Patient-Level Micro-Costing Study Across Modality and Provider Sector

    Vasileios Zavvos; John Fanourgiakis; Michael A. Talias dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Background: Dialysis is a life-sustaining but resource-intensive treatment for patients with kidney failure. Contemporary Greek evidence on the public-payer cost of dialysis is limited, particularly for comparisons across modality, provider sector and treatment subtype. Methods: We performed a…

  15. Artikel Jurnal Teks lengkap

    Analysis of How the Term “Shall” Is Understood and Applied to the EU-HTA Regulation

    Mondher Toumi; Samuel Aballéa; Bruno Fallissard dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The European Health Technology Assessment (EU-HTA) Regulation extensively uses the word “shall”, and its use has caused confusion among audiences unfamiliar with legal terminology [...]

  16. Artikel Jurnal Teks lengkap

    A Real-World Clinical Trial Evaluating Satisfaction and Experiences with a Dexamethasone Mouth Film Compared to Corticosteroid Tablets as Rescue Medication for Moderate to Severe Acute Allergic Reactions

    Leif Bjermer; Göran Tornling; James Kereki dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Despite the need for immediate treatment during acute allergic reactions (AARs), many patients do not consistently carry medication. A new mouth-dissolving dexamethasone film offers a portable, easily administered alternative to corticosteroid tablets. This non-randomized, open-label…

  17. Artikel Jurnal Teks lengkap

    Multi-Criteria Decision-Making Framework for Sustainable Innovation Management in the Mexican Medical Device Manufacturing Industry: An Exploratory and Interdisciplinary Analysis

    José Cozain-Hernández; Josué Aarón López-Leyva; Miguel Angel Ponce-Camacho dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The medical device manufacturing industry in Mexico faces a critical risk of losing competitiveness and sustainability due to its concentration on low-value-added manufacturing activities and limited integration into advanced stages of the value chain, such as R&D. This research addresses the lack…

  18. Artikel Jurnal Teks lengkap

    Market Care and Custody: A Health Policy Analysis of Incarceration and Long-Term Care Systems in the U.S.

    Travis W. Milburn; Iffath Unissa Syed

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The United States has one of the world’s largest criminal justice systems, with nearly 5.5 million people under correctional supervision and almost 2 million incarcerated. This scale of confinement, coupled with the rise of privatization across correctional and related services, reflects a broader…

  19. Artikel Jurnal Teks lengkap

    Epistemological Tensions in the EU HTA Joint Clinical Assessment: The Illusion of Judgment-Free Evaluation

    Mondher Toumi; Bruno Falissard; Asma Jouini dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    The practice of Health Technology Assessment (HTA) inherently involves moral, epistemological, and ontological commitments, which shape how assessments are conducted, interpreted, and used for decision-making [...]

  20. Artikel Jurnal Teks lengkap

    The Analytical Framework of Clinical Trials Evaluating Clinical Outcomes of Artificial Intelligence-Based Digital Health Interventions: A Systematic Literature Review

    Vladimir Zah; Dimitrije Grbic; Carl Asche dkk.

    Journal of Market Access & Health Policy, Vol. 14 No. 3 · 2026 · Inggris · DOAJ Scopus

    Introduction: This systematic literature review (SLR) provides an analytical framework for clinical trials evaluating clinical outcomes of artificial intelligence-based digital health interventions (AI-DHI). Methods: The SLR was conducted in accordance with the PRISMA guidelines. Search was…